Open AccessPreclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H. pylori immunostimulatory bacterial transgene
Author(s) -
Kimberly Viker,
Michael B. Steele,
Ianko Iankov,
Susanna C. Concilio,
Arun Ammayappan,
Brad Bolon,
Nathan J. Jenks,
Matthew P. Goetz,
Eleni Panagioti,
Mark J. Federspiel,
Minetta C. Liu,
Kah Whye Peng,
Evanthia Galanis
Publication year - 2022
Publication title -
molecular therapy — methods and clinical development
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.285
H-Index - 32
ISSN - 2329-0501
DOI - 10.1016/j.omtm.2022.07.014
Subject(s) - oncolytic virus , measles virus , nap , virology , transgene , strain (injury) , microbiology and biotechnology , measles , biology , virus , gene , vaccination , genetics , neuroscience , anatomy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom